Kinnate Biopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch KNTE and buy or sell other stocks, options, and ETFs commission-free!About KNTE
Kinnate Biopharma develops precision oncology therapeutics to treat patients with genomically-defined cancers. Its mission is to expand the reach of targeted therapeutics by developing products for underserved populations.
CEONima M. Farzan, MBA
CEONima M. Farzan, MBA
Employees27
Employees27
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2018
Founded2018
Employees27
Employees27
KNTE Key Statistics
Market cap124.88M
Market cap124.88M
Price-Earnings ratio-1.09
Price-Earnings ratio-1.09
Dividend yield—
Dividend yield—
Average volume367.46K
Average volume367.46K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$6.00
52 Week high$6.00
52 Week low$1.04
52 Week low$1.04